FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626323418> ?p ?o ?g. }

• W2626323418 endingPage "1482" @default.
• W2626323418 startingPage "1473" @default.
• W2626323418 abstract "To individualize timing of infliximab (IFX) treatment in children and adolescents with inflammatory bowel disease (IBD) using a patient-managed eHealth program.Patients with IBD, 10 to 17 years old, treated with IFX were prospectively included. Starting 4 weeks after their last infusion, patients reported a weekly symptom score and provided a stool sample for fecal calprotectin analysis. Based on symptom scores and fecal calprotectin results, the eHealth program calculated a total inflammation burden score that determined the timing of the next IFX infusion (4-12 wk after the previous infusion). Quality of Life was scored by IMPACT III. A control group was included to compare trough levels of IFX antibodies and concentrations and treatment intervals. Patients and their parents evaluated the eHealth program.There were 29 patients with IBD in the eHealth group and 21 patients with IBD in the control group. During the control period, 94 infusions were provided in the eHealth group (mean interval 9.5 wk; SD 2.3) versus 105 infusions in the control group (mean interval 6.9 wk; SD 1.4). Treatment intervals were longer in the eHealth group (P < 0.001). Quality of Life did not change during the study. Appearance of IFX antibodies did not differ between the 2 groups. Eighty percent of patients reported increased disease control and 63% (86% of parents) reported an improved knowledge of the disease.Self-managed, eHealth-individualized timing of IFX treatments, with treatment intervals of 4 to 12 weeks, was accompanied by no significant development of IFX antibodies. Patients reported better control and improved knowledge of their IBD." @default.
• W2626323418 created "2017-06-23" @default.
• W2626323418 creator A5002919479 @default.
• W2626323418 creator A5020584664 @default.
• W2626323418 creator A5049724966 @default.
• W2626323418 creator A5049877019 @default.
• W2626323418 creator A5060715363 @default.
• W2626323418 creator A5082697920 @default.
• W2626323418 creator A5084945169 @default.
• W2626323418 creator A5087463104 @default.
• W2626323418 date "2017-09-01" @default.
• W2626323418 modified "2023-10-11" @default.
• W2626323418 title "Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease" @default.
• W2626323418 cites W1487398079 @default.
• W2626323418 cites W1964428715 @default.
• W2626323418 cites W1981017999 @default.
• W2626323418 cites W1996039186 @default.
• W2626323418 cites W2003498729 @default.
• W2626323418 cites W2003835888 @default.
• W2626323418 cites W2009025779 @default.
• W2626323418 cites W2019804961 @default.
• W2626323418 cites W2026173148 @default.
• W2626323418 cites W2043780895 @default.
• W2626323418 cites W2085628255 @default.
• W2626323418 cites W2107045048 @default.
• W2626323418 cites W2117212747 @default.
• W2626323418 cites W2122667831 @default.
• W2626323418 cites W2135936774 @default.
• W2626323418 cites W2160011929 @default.
• W2626323418 cites W2167806388 @default.
• W2626323418 cites W2171059179 @default.
• W2626323418 cites W2171297959 @default.
• W2626323418 cites W2171392253 @default.
• W2626323418 cites W2330344211 @default.
• W2626323418 cites W2574762966 @default.
• W2626323418 cites W4236087740 @default.
• W2626323418 doi "https://doi.org/10.1097/mib.0000000000001170" @default.
• W2626323418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28617758" @default.
• W2626323418 hasPublicationYear "2017" @default.
• W2626323418 type Work @default.
• W2626323418 sameAs 2626323418 @default.
• W2626323418 citedByCount "38" @default.
• W2626323418 countsByYear W26263234182017 @default.
• W2626323418 countsByYear W26263234182018 @default.
• W2626323418 countsByYear W26263234182019 @default.
• W2626323418 countsByYear W26263234182020 @default.
• W2626323418 countsByYear W26263234182021 @default.
• W2626323418 countsByYear W26263234182022 @default.
• W2626323418 countsByYear W26263234182023 @default.
• W2626323418 crossrefType "journal-article" @default.
• W2626323418 hasAuthorship W2626323418A5002919479 @default.
• W2626323418 hasAuthorship W2626323418A5020584664 @default.
• W2626323418 hasAuthorship W2626323418A5049724966 @default.
• W2626323418 hasAuthorship W2626323418A5049877019 @default.
• W2626323418 hasAuthorship W2626323418A5060715363 @default.
• W2626323418 hasAuthorship W2626323418A5082697920 @default.
• W2626323418 hasAuthorship W2626323418A5084945169 @default.
• W2626323418 hasAuthorship W2626323418A5087463104 @default.
• W2626323418 hasBestOaLocation W26263234181 @default.
• W2626323418 hasConcept C126322002 @default.
• W2626323418 hasConcept C159110408 @default.
• W2626323418 hasConcept C160735492 @default.
• W2626323418 hasConcept C162324750 @default.
• W2626323418 hasConcept C1862650 @default.
• W2626323418 hasConcept C202645933 @default.
• W2626323418 hasConcept C2777138892 @default.
• W2626323418 hasConcept C2778260677 @default.
• W2626323418 hasConcept C2778292693 @default.
• W2626323418 hasConcept C2779008522 @default.
• W2626323418 hasConcept C2779134260 @default.
• W2626323418 hasConcept C2779951463 @default.
• W2626323418 hasConcept C50522688 @default.
• W2626323418 hasConcept C71924100 @default.
• W2626323418 hasConcept C90924648 @default.
• W2626323418 hasConceptScore W2626323418C126322002 @default.
• W2626323418 hasConceptScore W2626323418C159110408 @default.
• W2626323418 hasConceptScore W2626323418C160735492 @default.
• W2626323418 hasConceptScore W2626323418C162324750 @default.
• W2626323418 hasConceptScore W2626323418C1862650 @default.
• W2626323418 hasConceptScore W2626323418C202645933 @default.
• W2626323418 hasConceptScore W2626323418C2777138892 @default.
• W2626323418 hasConceptScore W2626323418C2778260677 @default.
• W2626323418 hasConceptScore W2626323418C2778292693 @default.
• W2626323418 hasConceptScore W2626323418C2779008522 @default.
• W2626323418 hasConceptScore W2626323418C2779134260 @default.
• W2626323418 hasConceptScore W2626323418C2779951463 @default.
• W2626323418 hasConceptScore W2626323418C50522688 @default.
• W2626323418 hasConceptScore W2626323418C71924100 @default.
• W2626323418 hasConceptScore W2626323418C90924648 @default.
• W2626323418 hasIssue "9" @default.
• W2626323418 hasLocation W26263234181 @default.
• W2626323418 hasLocation W26263234182 @default.
• W2626323418 hasOpenAccess W2626323418 @default.
• W2626323418 hasPrimaryLocation W26263234181 @default.
• W2626323418 hasRelatedWork W1997465236 @default.
• W2626323418 hasRelatedWork W2027190512 @default.
• W2626323418 hasRelatedWork W2090228779 @default.
• W2626323418 hasRelatedWork W2105895988 @default.

• next